CMM-308: Intradiscal Procedures

Evicore CMM-308 deems intradiscal procedures (e.g., IDET/IEA, nucleoplasty, biacuplasty, coblation, targeted disc decompression and intradiscal injectates such as PRP, stem cells, ozone, methylene blue, etc.) experimental, investigational, or unproven and identifies no covered indications. The guideline specifies no patient-selection, frequency, age, or documentation criteria and directs providers to individual payors for coverage decisions and any prior-authorization requirements.

"None — the guideline states intradiscal procedures are considered experimental, investigational, or unproven and their effectiveness has not been established: "Based on the lack of conclusive scien..."

Sign up to see full coverage criteria, indications, and limitations.